{"database": "openregs", "table": "federal_register", "rows": [["2020-21463", "Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff; Availability", "Notice", "The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled \"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use.\" This guidance describes studies and information that FDA recommends be used when submitting premarket notifications (510(k)s) for blood glucose monitoring systems (BGMSs) that are for prescription point-of-care use.", "2020-09-29", 2020, 9, "https://www.federalregister.gov/documents/2020/09/29/2020-21463/blood-glucose-monitoring-test-systems-for-prescription-point-of-care-use-guidance-for-industry-and", "https://www.govinfo.gov/content/pkg/FR-2020-09-29/pdf/2020-21463.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled \"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use.\" This guidance describes studies and information that FDA recommends...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2020-21463"], "units": {}, "query_ms": 0.46037399442866445, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}